| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jun―03 |
Discovery of PF-07817883, a second-generation oral SARS-CoV2 main protease inhibitor |
Amit Kalgutkar |
| 2 |
[GO] |
2025―Jun―03 |
COVID-19 severity dysregulates the expression of clinically relevant drug processing genes |
Chukwunonso Nwabufo, Jessica Luc, Allison McGeer, Jeremy Hirota, Samira Mubareka, Andrew Doxey, Theo Moraes |
| 3 |
[GO] |
2024―Mai―13 |
The effect of clofazimine in modulating intracellular concentrations of remdesivir and GS-441524: A potential mechanism of enhancing antiviral effects against SARS-COV-2 |
Md Rasheduzzaman Jony, Jae Gook Shin, Yong Soon Cho, Saurav Howlader, Dong Hyun Kim |
| 4 |
[GO] |
2023―Sep―01 |
A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19 |
Takeshi Tomida, Kotaro Itohara, Kazuhiro Yamamoto, Takeshi Kimura, Kohei Fujita, Atsushi Uda, et al. (+5) Yumi Kitahiro, Naoki Yokoyama, Yoji Hyodo, Tomohiro Omura, Ikuko Yano |
| 5 |
[GO] |
2021―Okt―12 |
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs |
Yuta Suzuki, Hiroshi Ishihara |
|
